{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:01:16Z","timestamp":1793944876632,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Fdn#154332"],"award-info":[{"award-number":["Fdn#154332"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008453","name":"Ontario Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    T cells are pivotal effectors of the immune system and can be harnessed as therapeutics for regenerative medicine and cancer immunotherapy. An unmet challenge in the field is the development of a clinically relevant system that is readily scalable to generate large numbers of T-lineage cells from hematopoietic stem\/progenitor cells (HSPCs). Here, we report a stromal cell-free, microbead-based approach that supports the efficient in vitro development of both human progenitor T (proT) cells and T-lineage cells from CD34\n                    <jats:sup>+<\/jats:sup>\n                    cells sourced from cord blood, GCSF-mobilized peripheral blood, and pluripotent stem cells (PSCs). DL4-\u03bcbeads, along with lymphopoietic cytokines, induce an ordered sequence of differentiation from CD34\n                    <jats:sup>+<\/jats:sup>\n                    cells to CD34\n                    <jats:sup>+<\/jats:sup>\n                    CD7\n                    <jats:sup>+<\/jats:sup>\n                    CD5\n                    <jats:sup>+<\/jats:sup>\n                    proT cells to CD3\n                    <jats:sup>+<\/jats:sup>\n                    \u03b1\u03b2 T cells. Single-cell RNA sequencing of human PSC-derived proT cells reveals a transcriptional profile similar to the earliest thymocytes found in the embryonic and fetal thymus. Furthermore, the adoptive transfer of CD34\n                    <jats:sup>+<\/jats:sup>\n                    CD7\n                    <jats:sup>+<\/jats:sup>\n                    proT cells into immunodeficient mice demonstrates efficient thymic engraftment and functional maturation of peripheral T cells. DL4-\u03bcbeads provide a simple and robust platform to both study human T cell development and facilitate the development of engineered T cell therapies from renewable sources.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-25245-8","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T06:14:09Z","timestamp":1629267249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["DL4-\u03bcbeads induce T cell lineage differentiation from stem cells in a stromal cell-free system"],"prefix":"10.1038","volume":"12","author":[{"given":"Ashton C.","family":"Trotman-Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Mohtashami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2006-3992","authenticated-orcid":false,"given":"Joshua","family":"De Sousa Casal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa C.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintia","family":"Teichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-5204","authenticated-orcid":false,"given":"Patrick M.","family":"Brauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8820-5910","authenticated-orcid":false,"given":"Michele K.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-3178","authenticated-orcid":false,"given":"Juan Carlos","family":"Z\u00fa\u00f1iga-Pfl\u00fccker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"25245_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2013.07.002","volume":"39","author":"M Kalos","year":"2013","unstructured":"Kalos, M. & June, C. H. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. Immunity 39, 49\u201360 (2013).","journal-title":"Immunity"},{"key":"25245_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12418","volume":"271","author":"MS Chaudhry","year":"2016","unstructured":"Chaudhry, M. S., Velardi, E., Dudakov, J. A. & van den Brink, M. R. Thymus: the next (re)generation. Immunol. Rev. 271, 56\u201371 (2016).","journal-title":"Immunol. Rev."},{"key":"25245_CR3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/intimm\/dxy051","volume":"30","author":"J Singh","year":"2018","unstructured":"Singh, J. & Zuniga-Pflucker, J. C. Producing proT cells to promote immunotherapies. Int Immunol. 30, 541\u2013550 (2018).","journal-title":"Int Immunol."},{"key":"25245_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2015.03.011","volume":"16","author":"M Themeli","year":"2015","unstructured":"Themeli, M., Riviere, I. & Sadelain, M. New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell 16, 357\u2013366 (2015).","journal-title":"Cell Stem Cell"},{"key":"25245_CR5","doi-asserted-by":"crossref","unstructured":"Depil, S. et al.\u00a0\u2018Off-the-shelf\u2019 allogeneic CAR T cells: development and challenges.\u00a0Nat Rev Drug Discov\u00a019,\u00a0185\u2013199 (2020).","DOI":"10.1038\/s41573-019-0051-2"},{"key":"25245_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1074-7613(02)00474-0","volume":"17","author":"TM Schmitt","year":"2002","unstructured":"Schmitt, T. M. & Zuniga-Pflucker, J. C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17, 749\u2013756 (2002).","journal-title":"Immunity"},{"key":"25245_CR7","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/stem.1145","volume":"30","author":"C Reimann","year":"2012","unstructured":"Reimann, C. et al. Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 culture system promote T-cell reconstitution in NOD\/SCID\/gammac(\u2212\/\u2212) mice. Stem Cells 30, 1771\u20131780 (2012).","journal-title":"Stem Cells"},{"key":"25245_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.4237","volume":"14","author":"CS Seet","year":"2017","unstructured":"Seet, C. S. et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat. Methods 14, 521\u2013530 (2017).","journal-title":"Nat. Methods"},{"key":"25245_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41578-019-0100-9","volume":"4","author":"S Kim","year":"2019","unstructured":"Kim, S., Shah, S. B., Graney, P. L. & Singh, A. Multiscale engineering of immune cells and lymphoid organs. Nat. Rev. Mater. 4, 355\u2013378 (2019).","journal-title":"Nat. Rev. Mater."},{"key":"25245_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.it.2016.09.008","volume":"37","author":"PM Brauer","year":"2016","unstructured":"Brauer, P. M., Singh, J., Xhiku, S. & Zuniga-Pflucker, J. C. T cell genesis: in vitro veritas est? Trends Immunol. 37, 889\u2013901 (2016).","journal-title":"Trends Immunol."},{"key":"25245_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nri1257","volume":"4","author":"JC Zuniga-Pflucker","year":"2004","unstructured":"Zuniga-Pflucker, J. C. T-cell development made simple. Nat. Rev. Immunol. 4, 67\u201372 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"25245_CR12","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1182\/blood-2004-04-1293","volume":"105","author":"RN La Motte-Mohs","year":"2005","unstructured":"La Motte-Mohs, R. N., Herer, E. & Zuniga-Pflucker, J. C. Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105, 1431\u20131439 (2005).","journal-title":"Blood"},{"key":"25245_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.stem.2018.12.011","volume":"24","author":"A Montel-Hagen","year":"2019","unstructured":"Montel-Hagen, A. et al. Organoid-induced differentiation of conventional T cells from human pluripotent stem cells. Cell Stem Cell 24, 376\u2013389 e378 (2019).","journal-title":"Cell Stem Cell"},{"key":"25245_CR14","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/eji.201444681","volume":"45","author":"N Gehre","year":"2015","unstructured":"Gehre, N. et al. A stromal cell free culture system generates mouse pro-T cells that can reconstitute T-cell compartments in vivo. Eur. J. Immunol. 45, 932\u2013942 (2015).","journal-title":"Eur. J. Immunol."},{"key":"25245_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1188995","volume":"329","author":"T Ikawa","year":"2010","unstructured":"Ikawa, T. et al. An essential developmental checkpoint for production of the T cell lineage. Science 329, 93\u201396 (2010).","journal-title":"Science"},{"key":"25245_CR16","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1182\/blood-2006-08-039842","volume":"109","author":"MH Dallas","year":"2007","unstructured":"Dallas, M. H., Varnum-Finney, B., Martin, P. J. & Bernstein, I. D. Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1. Blood 109, 3579\u20133587 (2007).","journal-title":"Blood"},{"key":"25245_CR17","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/blood-2002-06-1862","volume":"101","author":"B Varnum-Finney","year":"2003","unstructured":"Varnum-Finney, B., Brashem-Stein, C. & Bernstein, I. D. Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 101, 1784\u20131789 (2003).","journal-title":"Blood"},{"key":"25245_CR18","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jaci.2017.10.034","volume":"141","author":"L Simons","year":"2018","unstructured":"Simons, L. et al. Generation of adult human T-cell progenitors for immunotherapeutic applications. J. Allergy Clin. Immunol. 141, 1491\u20131494 e1494 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"25245_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nmeth.4258","volume":"14","author":"S Shukla","year":"2017","unstructured":"Shukla, S. et al. Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1. Nat. Methods 14, 531\u2013538 (2017).","journal-title":"Nat. Methods"},{"key":"25245_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.biotechadv.2011.06.009","volume":"29","author":"CAV Rodrigues","year":"2011","unstructured":"Rodrigues, C. A. V., Fernandes, T. G., Diogo, M. M., da Silva, C. L. & Cabral, J. M. S. Stem cell cultivation in bioreactors. Biotechnol. Adv. 29, 815\u2013829 (2011).","journal-title":"Biotechnol. Adv."},{"key":"25245_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/elsc.201300013","volume":"14","author":"N Liu","year":"2014","unstructured":"Liu, N., Zang, R., Yang, S. T. & Li, Y. Stem cell engineering in bioreactors for large-scale bioprocessing. Eng. Life Sci. 14, 4\u201315 (2014).","journal-title":"Eng. Life Sci."},{"key":"25245_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2008-10-187013","volume":"114","author":"G Awong","year":"2009","unstructured":"Awong, G. et al. Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood 114, 972\u2013982 (2009).","journal-title":"Blood"},{"key":"25245_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ncb3161","volume":"17","author":"A Ditadi","year":"2015","unstructured":"Ditadi, A. et al. Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat. Cell Biol. 17, 580\u2013591 (2015).","journal-title":"Nat. Cell Biol."},{"key":"25245_CR24","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1084\/jem.20182363","volume":"216","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. Yeats4 drives ILC lineage commitment via activation of Lmo4 transcription. J. Exp. Med. 216, 2653\u20132668 (2019).","journal-title":"J. Exp. Med."},{"key":"25245_CR25","unstructured":"Park, J. E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science\u00a0367, eaay3224 (2020)."},{"issue":"Pt 23","key":"25245_CR26","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1242\/jcs.113.23.4313","volume":"113","author":"B Varnum-Finney","year":"2000","unstructured":"Varnum-Finney, B. et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J. Cell Sci. 113(Pt 23), 4313\u20134318 (2000).","journal-title":"J. Cell Sci."},{"key":"25245_CR27","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.1038\/mtm.2014.15","volume":"1","author":"P Bajgain","year":"2014","unstructured":"Bajgain, P. et al. Optimizing the production of suspension cells using the G-Rex \u201cM\u201d series. Mol. Ther. Methods Clin. Dev. 1, 14015 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"25245_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/jbm.a.30916","volume":"79","author":"S Taqvi","year":"2006","unstructured":"Taqvi, S., Dixit, L. & Roy, K. Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells. J. Biomed. Mater. Res A 79, 689\u2013697 (2006).","journal-title":"J. Biomed. Mater. Res A"},{"key":"25245_CR29","first-page":"19","volume":"360","author":"DK Shah","year":"2012","unstructured":"Shah, D. K. & Zuniga-Pflucker, J. C. Notch receptor-ligand interactions during T cell development, a ligand endocytosis-driven mechanism. Curr. Top. Microbiol. Immunol. 360, 19\u201346 (2012).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"25245_CR30","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1242\/dev.01789","volume":"132","author":"R Le Borgne","year":"2005","unstructured":"Le Borgne, R., Bardin, A. & Schweisguth, F. The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 132, 1751\u20131762 (2005).","journal-title":"Development"},{"key":"25245_CR31","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1021\/acs.nanolett.6b01403","volume":"16","author":"F Chowdhury","year":"2016","unstructured":"Chowdhury, F. et al. Defining single molecular forces required for notch activation using Nano Yoyo. Nano Lett. 16, 3892\u20133897 (2016).","journal-title":"Nano Lett."},{"key":"25245_CR32","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1158\/0008-5472.CAN-16-1149","volume":"76","author":"T Maeda","year":"2016","unstructured":"Maeda, T. et al. Regeneration of CD8 alphabeta T cells from T-cell-derived iPSC imparts potent tumor antigen-specific cytotoxicity. Cancer Res 76, 6839\u20136850 (2016).","journal-title":"Cancer Res"},{"key":"25245_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.stem.2012.12.006","volume":"12","author":"R Vizcardo","year":"2013","unstructured":"Vizcardo, R. et al. Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells. Cell Stem Cell 12, 31\u201336 (2013).","journal-title":"Cell Stem Cell"},{"key":"25245_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20658-3","volume":"12","author":"S Iriguchi","year":"2021","unstructured":"Iriguchi, S. et al. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy. Nat. Commun. 12, 430 (2021).","journal-title":"Nat. Commun."},{"key":"25245_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2172-12-22","volume":"12","author":"G Awong","year":"2011","unstructured":"Awong, G., Herer, E., La Motte-Mohs, R. N. & Zuniga-Pflucker, J. C. Human CD8 T cells generated in vitro from hematopoietic stem cells are functionally mature. BMC Immunol. 12, 22 (2011).","journal-title":"BMC Immunol."},{"key":"25245_CR36","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1182\/blood-2012-12-472803","volume":"122","author":"G Awong","year":"2013","unstructured":"Awong, G. et al. Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood 122, 4210\u20134219 (2013).","journal-title":"Blood"},{"key":"25245_CR37","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.3324\/haematol.2016.154740","volume":"102","author":"MR Lidonnici","year":"2017","unstructured":"Lidonnici, M. R. et al. Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone. Haematologica 102, e120\u2013e124 (2017).","journal-title":"Haematologica"},{"key":"25245_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm.2016.127","volume":"18","author":"A Ditadi","year":"2017","unstructured":"Ditadi, A., Sturgeon, C. M. & Keller, G. A view of human haematopoietic development from the Petri dish. Nat. Rev. Mol. Cell Biol. 18, 56\u201367 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"25245_CR39","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.celrep.2012.11.003","volume":"2","author":"M Kennedy","year":"2012","unstructured":"Kennedy, M. et al. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep. 2, 1722\u20131735 (2012).","journal-title":"Cell Rep."},{"key":"25245_CR40","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1002\/stem.2115","volume":"33","author":"MJ Smith","year":"2015","unstructured":"Smith, M. J. et al. In Vitro T-cell generation from adult, embryonic, and induced pluripotent stem cells: many roads to one destination. Stem Cells 33, 3174\u20133180 (2015).","journal-title":"Stem Cells"},{"key":"25245_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41556-019-0445-8","volume":"22","author":"A Motazedian","year":"2020","unstructured":"Motazedian, A. et al. Multipotent RAG1+ progenitors emerge directly from haemogenic endothelium in human pluripotent stem cell-derived haematopoietic organoids. Nat. Cell Biol. 22, 60\u201373 (2020).","journal-title":"Nat. Cell Biol."},{"key":"25245_CR42","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nature22370","volume":"545","author":"R Sugimura","year":"2017","unstructured":"Sugimura, R. et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 545, 432\u2013438 (2017).","journal-title":"Nature"},{"key":"25245_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41422-019-0251-7","volume":"30","author":"R Guo","year":"2020","unstructured":"Guo, R. et al. Guiding T lymphopoiesis from pluripotent stem cells by defined transcription factors. Cell Res 30, 21\u201333 (2020).","journal-title":"Cell Res"},{"key":"25245_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature25435","volume":"553","author":"LT Vo","year":"2018","unstructured":"Vo, L. T. et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature 553, 506\u2013510 (2018).","journal-title":"Nature"},{"key":"25245_CR45","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1038\/onc.2008.229","volume":"27","author":"B D\u2019Souza","year":"2008","unstructured":"D\u2019Souza, B., Miyamoto, A. & Weinmaster, G. The many facets of Notch ligands. Oncogene 27, 5148\u20135167 (2008).","journal-title":"Oncogene"},{"key":"25245_CR46","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nbt.3294","volume":"33","author":"M Ogawa","year":"2015","unstructured":"Ogawa, M. et al. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat. Biotechnol. 33, 853\u2013861 (2015).","journal-title":"Nat. Biotechnol."},{"key":"25245_CR47","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/physrev.00005.2017","volume":"97","author":"C Siebel","year":"2017","unstructured":"Siebel, C. & Lendahl, U. Notch signaling in development, tissue homeostasis, and disease. Physiol. Rev. 97, 1235\u20131294 (2017).","journal-title":"Physiol. Rev."},{"key":"25245_CR48","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.celrep.2018.05.068","volume":"23","author":"ME Kirkling","year":"2018","unstructured":"Kirkling, M. E. et al. Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells. Cell Rep. 23, 3658\u20133672 e3656 (2018).","journal-title":"Cell Rep."},{"key":"25245_CR49","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1016\/0022-1759(82)90269-1","volume":"49","author":"G Fazekas de St","year":"1982","unstructured":"Fazekas de St, G. The evaluation of limiting dilution assays. J. Immunol. Methods 49, R11\u201323 (1982).","journal-title":"J. Immunol. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25245-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:57:57Z","timestamp":1725638277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25245-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25245"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25245-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have submitted a patent describing the method of generating cells of the T-lineage using DL4-\u03bcbeads. AC.T.G., M.M., and J.C.Z.-P. are co-founders and shareholders of Notch Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5023"}}